Medical Testing

Not to be sniffed at: Agony of post-COVID-19 loss of smell

Tue, 2021-02-23 12:01 — mike kraft

Researchers still investigating loss of smell problems among some of Covid victims

... A year into the coronavirus pandemic, doctors and researchers are still striving to better understand and treat the accompanying epidemic of COVID-19-related anosmia — loss of smell — draining much of the joy of life from an increasing number of sensorially frustrated longer-term sufferers like Forgione.

Even specialist doctors say there is much about the condition they still don’t know and they are learning as they go along in their diagnoses and treatments. Impairment and alteration of smell have become so common with COVID-19 that some researchers suggest that simple odor tests could be used to track coronavirus infections in countries with few laboratories.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Not to be sniffed at: Agony of post-COVID-19 loss of smell
Log in or register to post comments

FDA new guidance: Vaccines Adapted for Variants Will Not Need Lengthy Testing

Tue, 2021-02-23 10:04 — mike kraft

The Food and Drug Administration said on Monday that vaccine developers would not need to conduct lengthy randomized controlled trials for vaccines that have been adapted to protect against concerning coronavirus variants.

The recommendations, which call for small trials more like those required for annual flu vaccines, would greatly accelerate the review process at a time when scientists are increasingly anxious about how the variants might slow or reverse progress made against the virus.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about FDA new guidance: Vaccines Adapted for Variants Will Not Need Lengthy Testing
Log in or register to post comments

TheHill.com Johnson & Johnson ready to provide doses for 20M Americans by end of March

Mon, 2021-02-22 20:14 — mike kraft

Johnson & Johnson ready to provide doses for 20M Americans by end of Johnson & Johnson said Monday that it plans to have enough doses of its vaccine for more than 20 million Americans by the end of March if its vaccine is authorized by the Food and Drug Administration. Peter Sullivan TheHill

Johnson & Johnson said Monday that it plans to have enough doses of its vaccine for more than 20 million Americans by the end of March if its vaccine is authorized by the Food and Drug Administration.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about TheHill.com Johnson & Johnson ready to provide doses for 20M Americans by end of March
Log in or register to post comments

FDA issues alert on ‘limitations’ of pulse oximeters, which have accuracy problems with darker skin personsth

Mon, 2021-02-22 19:48 — mike kraft

FDA issues alert on the 'limitations' of pulse oximeters Experts and lawmakers have expressed concern about potential racial disparities in the readings of pulse oximeters. Erin Brodwin STAT

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Although US Covid-19 numbers may be slowing experts project tens of thousands more deaths in next 3 months

Sun, 2021-02-21 11:13 — mike kraft

US Covid-19 numbers may be slowing but experts project tens of thousands more deaths in next 3 months Covid-19 trends may be encouraging in recent weeks -- but a new forecast offered a grim reminder the US is not in the clear. Christina Maxouris, CNN CNN

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

ANALYSIS: Most vaccine clinical trials fail to report data on participants’ ethnicity or race

Fri, 2021-02-19 12:33 — mike kraft

Most vaccine trials fail to report data on participant ethnicity or race - STAT Of the 230 trials researchers examined, more than 40% did not record participants’ race and about 65% did not report their ethnicity. Nicholas St. Fleur STAT

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about ANALYSIS: Most vaccine clinical trials fail to report data on participants’ ethnicity or race
Log in or register to post comments

The difficulties in enrolling teenagers for vaccine test trials.

Thu, 2021-02-18 11:06 — mike kraft

Teenagers contract the novel coronavirus almost twice as often as younger children but vaccines authorized in the United States are mostly for adults — Moderna’s for 18 and older, Pfizer’s for 16 and up.

Country / Region Tags:

General Topic Tags: